Drug Trial Radar · NCT05797831
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Last checked: Nov 19, 2026Latest source record: May 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
268
Planned (sponsor's estimate)
Start
Jul 17, 2023
Primary completion
Aug 2025
Study completion Jul 2027
Sponsor
- Lead sponsor
- Kartos Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- European Network of Gynaecological Oncological Trial Groups (ENGOT); GOG Foundation
- First posted
- Apr 4, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have achieved complete response or partial response on chemotherapy. The study will be conducted in 2 parts. Part 1 will evaluate safety and efficacy of two different doses of navtemadlin alongside an observational control arm to determine the Phase 3 navtemadlin dose. Part 2 will evaluate the efficacy and safety of navtemadlin Phase 3 dose compared to placebo.
Conditions
- Endometrial Cancer
Interventions
NavtemadlinDrug
Navtemadlin is an experimental MDM2 anticancer drug taken by mouth
Navtemadlin PlaceboDrug
Navtemadlin placebo is a placebo that is the same in appearance to navtemadlin drug taken by mouth
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part 1: To determine the navtemadlin Phase 3 doseTime frame: 12 months
- Part 2: To compare progression-free (PFS) survival by independent review committee (IRC) between navtemadlin and placeboTime frame: 50 months
Locations
83 sites in 17 countries. Site status is shown where the registry gives one.
Kaiser Permanente Center
Vallejo, California · Recruiting
Northside Hospital
Atlanta, Georgia · Recruiting
St. Joseph
Savannah, Georgia · Recruiting
Dr. Sudarshan K. Sharma, Ltd.
Hinsdale, Illinois · Recruiting
Parkview Research Center
Fort Wayne, Indiana · Recruiting
Indiana University
Indianapolis, Indiana · Recruiting
Maryland Oncology Hematology, P.A.
Silver Spring, Maryland · Recruiting
Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Women's Cancer Center of Nevada
Las Vegas, Nevada · Recruiting
Good Samaritan Hospital Medical Center
West Islip, New York · Recruiting
FirstHealth Carolinas
Pinehurst, North Carolina · Recruiting
OhioHealth Institute
Columbus, Ohio · Recruiting
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma · Recruiting
Oncology Associates of Oregon
Eugene, Oregon · Recruiting
Northwest Cancer Specialists
Portland, Oregon · Recruiting
Texas Oncology-Austin Central
Austin, Texas · Recruiting
Texas Oncology-Fort Worth Cancer Center
Fort Worth, Texas · Recruiting
Texas Oncology-San Antonio Medical Center
San Antonio, Texas · Recruiting
University Hospital Graz, Department of Gynecology and Obstetrics
Graz, Austria · Recruiting
Medizinische Universität Innsbruck
Innsbruck, Austria · Recruiting
Medizinische Universität Wien
Vienna, Austria · Recruiting
Cross Cancer Institute
Edmonton, Canada · Recruiting
CHUM - University of Montreal Hospital Centre
Montreal, Canada · Recruiting
Odense University Hospital
Odense, Denmark · Recruiting
Tartu University Hospital
Tartu, Estonia · Recruiting
Kuopio University Hospital
Kuopio, Finland · Recruiting
Turku University Hospital
Turku, Finland · Recruiting
LTD High Technology hospital Medcenter
Batumi, Georgia · Recruiting
American Hospital Network LLC
Tbilisi, Georgia · Recruiting
Caucasus Medical Centre
Tbilisi, Georgia · Recruiting
National Institute of Oncology
Budapest, Hungary · Recruiting
University of Debrecen Clinical Center
Debrecen, Hungary · Recruiting
Rambam Medical Center
Haifa, Israel · Recruiting
Shaare Zedek Medical Center
Jerusalem, Israel · Recruiting
Sourasky Medical Center
Tel Aviv, Israel · Recruiting
A.O. Cannizzaro
Catania, Italy · Recruiting
IRCCS Istituto Romangolo per lo Studio dei Tumori "Dino Amadori"
Forlì, Italy · Recruiting
Ospedale Policlinico San Martino
Genoa, Italy · Recruiting
ASST di Lecco-Ospedale Alessandro Manzoni
Lecco, Italy · Recruiting
Showing 40 of 83 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.